logo
What I'm packing for summer travel to beat jet lag, fix tummy problems and stay healthy

What I'm packing for summer travel to beat jet lag, fix tummy problems and stay healthy

Yahoo16 hours ago
Got the travel bug this summer? Just make sure you don't pick up any other bugs when you hit the road.
No matter where I go on vacation, I've always taken a fully-stocked mini medicine bag with the obvious essentials: painkillers, antacids, Band-aids, Lactaid and a little something for nausea.
But that medicine bag has grown a bit in recent years — especially since I've become The Post's wellness editor.
Now it includes a bunch of other things you might not think to pack, and they've made a massive difference in how I feel and function when I'm away from home.
To fall asleep and beat jet lag
I just got back from Hawaii, and between the 10.5-hour flight from New York and the 6-hour time difference, I knew the jet lag would be a beach — if you know what I mean.
A big reason we sleep so poorly while traveling is that our circadian rhythms get messed up from time differences.
Melatonin can help fix this.
That's because your body naturally produces melatonin in response to darkness at night, getting you ready for sleep. It usually happens on a pretty regular schedule, so when it gets out of whack when you take red-eyes or switch time zones, you can nudge it in the right direction with a supplement.
One of my favorites right now is Kourtney Kardashian's Lemme Sleep, a gummy with a yummy berry flavor that blends melatonin with L-theanine and magnesium — a key ingredient in the viral 'sleepy girl mocktail.'
I also love the Make Time for Beauty Sleep gummy, which has that special trio of melatonin, magnesium, and L-theanine too — plus biotin for skin, hair and nail health.
To stay hydrated
I used to get super sick from heat exhaustion and dehydration, so years ago when I went to Cambodia, I knew I needed to figure out a way to not die in the 100-degree heat.
At the time, Pedialyte was one of the only brands making travel-size electrolytes. Now there are a ton of great brands to choose from.
I'm currently loving Thorne (I'm partial to the mango limeade in the variety pack), FlavCity (pineapple coconut is my fave) and Groove (strawberry kiwi for the win).
I keep one in my purse so I can pour it into a water bottle if it's hot out, but they're also great for chugging after a night of cocktails so you wake up without a hangover. They key is to get those electrolytes in before you start feeling sick.
To get my tummy straight
Never had tummy problems while traveling? I don't believe you.
Even if you're really good about not overeating — and knowing which countries where you can't drink the water — sometimes, things get stuck. Or let loose. Or whatever other euphemism you prefer.
So here's a tip if you're constipated: Pack a fiber supplement. I've been using BelliWelli because they come in handy little travel-size packets in tasty flavors like watermelon and strawberry lemonade (and the branding's super cute).
Don't go crazy, though — that new 'fibermaxxing' trend has some downsides, as we recently reported.
To fight infections and stay healthy overall
Travel really presents the perfect recipe for illness — you're probably not sleeping enough, you're eating new things, and you're exposed to lots of people carrying who knows what germs.
Upping your vitamin intake before, during and after could help boost your immunity.
Barrière makes these adorable vitamin patches, from vitamin D3 stickers that look like suns to vitamin B12 ones that look like rainbows, hearts and palm trees.
I'm especially obsessed with the Travel Well patches, which have zinc and vitamin D3 — both essential for immune function — and elderberry, which may also support immune health.
I also like MegaFood's burpless omega-3 pills, since fish oil is kind of a magic ingredient for everything from immunity to heart health to brain function. And this one's got none of those gross fishy burps.
Finally, my least sexy recommendation — but something I absolutely can't live without: NeilMed's sinus rinse kit. If you've never done nasal irrigation before (like a NetiPot), it may take some getting used to. But when I'm using this nightly, I don't get colds. They just flush everything out.
It's also good for allergies and flu and COVID symptom relief — just make sure you're following the directions so you don't get a brain-eating amoeba.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Copa Holdings, S.A. (CPA) Reports 6.3% YoY Increase in Traffic for June; Citi and UBS Maintain Bullish Outlook
Copa Holdings, S.A. (CPA) Reports 6.3% YoY Increase in Traffic for June; Citi and UBS Maintain Bullish Outlook

Yahoo

time13 minutes ago

  • Yahoo

Copa Holdings, S.A. (CPA) Reports 6.3% YoY Increase in Traffic for June; Citi and UBS Maintain Bullish Outlook

Trading at a low P/E multiple with potential upside for investors, Copa Holdings, S.A. (NYSE:CPA) is among the . For June 2025, Copa Holdings, S.A. (NYSE:CPA) reported experiencing strong traffic, driven by continued demand for air travel across its network. The company reported a higher passenger volume with its Revenue Passenger Miles (RPM), a critical measure of airline traffic, increasing by 6.3% on a YoY basis. Copa Holdings, S.A. (NYSE:CPA) expanded its Available Seat Miles (ASM), a measure of the passenger-carrying capacity, by 5.3% from June 2024 to cater to the growing demand. Most importantly, traffic growth surpassed capacity expansion, improving the airline's load factor – a measure of how full flights are. The load factor increased to 87.5% in June 2025 from 86.6% in the previous year. This performance of the company boosts investors' confidence in CPA's operational strength and continued post-pandemic travel recovery momentum. Analysts are bullish on the stock, with Citi and UBS setting their price targets at $159 and $180, respectively. Copa Holdings, S.A. (NYSE:CPA), a Panama-based airline holding company, owns two airlines: Panama-based Copa Airlines and Colombia-based AeroRepública. It is on the list of cheap transportation stocks. While we acknowledge the potential of CPA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Billionaire Kerr Neilson's 10 Stock Picks with Huge Upside Potential and . Disclosure: None. Sign in to access your portfolio

Barclays Raises PT on American Airlines Group Inc. (AAL) Despite Weak Earnings Outlook
Barclays Raises PT on American Airlines Group Inc. (AAL) Despite Weak Earnings Outlook

Yahoo

time13 minutes ago

  • Yahoo

Barclays Raises PT on American Airlines Group Inc. (AAL) Despite Weak Earnings Outlook

With a low P/E multiple and potential upside for investors, American Airlines Group Inc. (NASDAQ:AAL) is among the . Pixabay/Public Domain On July 10, 2025, Barclays increased its price target on the American Airlines Group Inc. (NASDAQ:AAL) from $11 to $12, maintaining an 'Equal Weight' rating. The analysts at Barclays acknowledged that the airline earnings outlook is likely to stay weak amid higher jet fuel prices and continued weak U.S. leisure demand. However, they believe that if the company cuts its capacity in Q4, investors could react positively, given the resulting impact on pricing and profitability. Meanwhile, ahead of its Q2 2025 earnings announcement due on July 24, 2025, other analysts expect American Airlines Group Inc. (NASDAQ:AAL) to report a 27.5% decrease in earnings per share (EPS) to $0.79 per share and a slight revenue dip to $14.29 billion. The extent to which actual results vary from the forecasts could define the company's short-term outlook. At the same time, American Airlines Group Inc. (NASDAQ:AAL) is adding three new winter routes from Chicago and Philadelphia to Mexico City, Queretaro, and Santo Domingo. Furthermore, the airline will expand its seasonal service across Latin America, offering over 2.3 million round-trip passengers during the holiday season, which would be 1 million more than its closest competitor. American Airlines Group Inc. (NASDAQ:AAL) is a global network air carrier, providing scheduled air transportation services for passengers and cargo. It is on the list of cheap transportation stocks. While we acknowledge the potential of AAL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 7 Best Stocks to Invest in for a Quick Return and 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Sanofi concludes Blueprint Medicines acquisition
Sanofi concludes Blueprint Medicines acquisition

Yahoo

time13 minutes ago

  • Yahoo

Sanofi concludes Blueprint Medicines acquisition

Sanofi has completed its acquisition of Blueprint Medicines, enhancing its portfolio with a commercialised therapy and the expertise of a company focused on systemic mastocytosis (SM) and other KIT-driven diseases. In June 2025, Sanofi agreed to acquire Blueprint for an equity value of $9.1bn. The acquisition of Blueprint provides Sanofi with a well-established foothold among dermatologists, allergists and immunologists, which strengthens Sanofi's efforts in advancing its expanding immunology pipeline. It also includes Ayvakit/Ayvakyt (avapritinib), a treatment for rare immunological diseases that has received approval in both the US and the European Union. The acquisition also covers elenestinib, a treatment for SM. It is currently being evaluated in the HARBOR study, a Phase II/III clinical trial. This ongoing, randomised, double-blind, placebo-controlled study aims to assess the efficacy and safety of elenestinib in combination with symptom-directed therapy for patients with indolent ISM and SM. Sanofi has acquired BLU-808, an investigational oral medication that serves as a highly potent and selective inhibitor of wild-type KIT. The tender offer for all outstanding Blueprint common stock shares expired on 17 July 2025. All conditions were met, and Sanofi accepted and will pay for all valid tendered shares. Sanofi completed its acquisition of Blueprint through a merger, with the latter becoming a wholly owned subsidiary. The transaction is financed with cash and commercial paper proceeds and will not significantly impact Sanofi's 2025 financial guidance. It is expected to enhance gross margin and contribute positively to operating income and earnings per share after 2026. In mid-July 2025, Thermo Fisher announced the acquisition of Sanofi's sterile manufacturing facility in the US. The transaction is expected to be finalised in the second quarter of 2025, pending the usual closing conditions. "Sanofi concludes Blueprint Medicines acquisition" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store